These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34894233)

  • 1. Sex Differences in the Behavioral, Molecular, and Structural Effects of Ketamine Treatment in Depression.
    Ponton E; Turecki G; Nagy C
    Int J Neuropsychopharmacol; 2022 Jan; 25(1):75-84. PubMed ID: 34894233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex and Estrous Cycle Are Not Mediators of S-Ketamine's Rapid-Antidepressant Behavioral Effects in a Genetic Rat Model of Depression.
    Arjmand S; Vadstrup Pedersen M; Silva NR; Landau AM; Joca S; Wegener G
    Int J Neuropsychopharmacol; 2023 May; 26(5):350-358. PubMed ID: 37067203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine for treatment-resistant depression: recent developments and clinical applications.
    Schwartz J; Murrough JW; Iosifescu DV
    Evid Based Ment Health; 2016 May; 19(2):35-8. PubMed ID: 27053196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine.
    Wohleb ES; Gerhard D; Thomas A; Duman RS
    Curr Neuropharmacol; 2017; 15(1):11-20. PubMed ID: 26955968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
    Hashimoto K
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
    Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
    Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early life stress leads to sex differences in development of depressive-like outcomes in a mouse model.
    Goodwill HL; Manzano-Nieves G; Gallo M; Lee HI; Oyerinde E; Serre T; Bath KG
    Neuropsychopharmacology; 2019 Mar; 44(4):711-720. PubMed ID: 30188513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.
    Monteggia LM; Gideons E; Kavalali ET
    Biol Psychiatry; 2013 Jun; 73(12):1199-203. PubMed ID: 23062356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in the antidepressant-like effects of ketamine.
    Carrier N; Kabbaj M
    Neuropharmacology; 2013 Jul; 70():27-34. PubMed ID: 23337256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward specific ways to combine ketamine and psychotherapy in treating depression.
    Hasler G
    CNS Spectr; 2020 Jun; 25(3):445-447. PubMed ID: 31213212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
    Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
    Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on ketamine and its two enantiomers as rapid-acting antidepressants.
    Zhang K; Hashimoto K
    Expert Rev Neurother; 2019 Jan; 19(1):83-92. PubMed ID: 30513009
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on NMDA antagonists in depression.
    Pochwat B; Nowak G; Szewczyk B
    Expert Rev Neurother; 2019 Nov; 19(11):1055-1067. PubMed ID: 31328587
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of sex as a biological variable in the search for novel antidepressants.
    Williams AV; Trainor BC
    Front Neuroendocrinol; 2018 Jul; 50():107-117. PubMed ID: 29859882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis.
    Wang M; Zhang B; Zhou Y; Wang C; Zheng W; Liu W; Zhan Y; Lan X; Ning Y
    Pharmacol Rep; 2021 Apr; 73(2):594-603. PubMed ID: 33387333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
    Kim JW; Monteggia LM
    Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice.
    Thelen C; Sens J; Mauch J; Pandit R; Pitychoutis PM
    Behav Brain Res; 2016 Oct; 312():305-12. PubMed ID: 27343934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does ketamine elicit a rapid antidepressant response?
    Kavalali ET; Monteggia LM
    Curr Opin Pharmacol; 2015 Feb; 20():35-9. PubMed ID: 25462290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.